70 related articles for article (PubMed ID: 17625579)
1. Inhibition of tubule-cell proliferation to prevent cyst formation: a new avenue to treat ADPKD?
Bello-Reuss E
Kidney Int; 2007 Jul; 72(2):135-7. PubMed ID: 17625579
[TBL] [Abstract][Full Text] [Related]
2. Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system.
Parker E; Newby LJ; Sharpe CC; Rossetti S; Streets AJ; Harris PC; O'Hare MJ; Ong AC
Kidney Int; 2007 Jul; 72(2):157-65. PubMed ID: 17396115
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.
Liu C; Zhang Y; Yuan L; Fu L; Mei C
Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113
[TBL] [Abstract][Full Text] [Related]
4. Blockade of interleukin-8 receptor signalling inhibits cyst development in vitro, via suppression of cell proliferation in autosomal polycystic kidney disease.
Lee EJ; Song SA; Mun HW; Yoo KH; Choi SY; Park EY; Park JH
Nephrology (Carlton); 2014 Aug; 19(8):471-8. PubMed ID: 24724588
[TBL] [Abstract][Full Text] [Related]
5. Strategies to inhibit cyst formation in ADPKD.
Calvet JP
Clin J Am Soc Nephrol; 2008 Jul; 3(4):1205-11. PubMed ID: 18434615
[TBL] [Abstract][Full Text] [Related]
6. Olive leaf extract counteracts cell proliferation and cyst growth in an in vitro model of autosomal dominant polycystic kidney disease.
Toteda G; Vizza D; Lupinacci S; Perri A; Scalise MF; Indiveri C; Puoci F; Parisi OI; Lofaro D; La Russa A; Gigliotti P; Leone F; Pochini L; Bonofiglio R
Food Funct; 2018 Nov; 9(11):5925-5935. PubMed ID: 30375624
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.
Yamaguchi T; Nagao S; Wallace DP; Belibi FA; Cowley BD; Pelling JC; Grantham JJ
Kidney Int; 2003 Jun; 63(6):1983-94. PubMed ID: 12753285
[TBL] [Abstract][Full Text] [Related]
8. Ganoderma triterpenes retard renal cyst development by downregulating Ras/MAPK signaling and promoting cell differentiation.
Su L; Liu L; Jia Y; Lei L; Liu J; Zhu S; Zhou H; Chen R; Lu HAJ; Yang B
Kidney Int; 2017 Dec; 92(6):1404-1418. PubMed ID: 28709639
[TBL] [Abstract][Full Text] [Related]
9. Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.
Parker MI; Nikonova AS; Sun D; Golemis EA
Cell Signal; 2020 Mar; 67():109497. PubMed ID: 31830556
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
[TBL] [Abstract][Full Text] [Related]
11. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
[TBL] [Abstract][Full Text] [Related]
12. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease.
Wilson PD; Du J; Norman JT
Eur J Cell Biol; 1993 Jun; 61(1):131-8. PubMed ID: 8223698
[TBL] [Abstract][Full Text] [Related]
13. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease.
Nagao S; Yamaguchi T; Kusaka M; Maser RL; Takahashi H; Cowley BD; Grantham JJ
Kidney Int; 2003 Feb; 63(2):427-37. PubMed ID: 12631108
[TBL] [Abstract][Full Text] [Related]
14. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.
Yamaguchi T; Pelling JC; Ramaswamy NT; Eppler JW; Wallace DP; Nagao S; Rome LA; Sullivan LP; Grantham JJ
Kidney Int; 2000 Apr; 57(4):1460-71. PubMed ID: 10760082
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
[TBL] [Abstract][Full Text] [Related]
16. Colchicine treatment in autosomal dominant polycystic kidney disease: many points in common.
Solak Y; Atalay H; Polat I; Biyik Z
Med Hypotheses; 2010 Feb; 74(2):314-7. PubMed ID: 19765912
[TBL] [Abstract][Full Text] [Related]
17. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.
Loghman-Adham M; Nauli SM; Soto CE; Kariuki B; Zhou J
Am J Physiol Renal Physiol; 2003 Sep; 285(3):F397-412. PubMed ID: 12734101
[TBL] [Abstract][Full Text] [Related]
18. Aberrant epithelial cell growth in autosomal dominant polycystic kidney disease.
Wilson PD
Am J Kidney Dis; 1991 Jun; 17(6):634-7. PubMed ID: 2042637
[TBL] [Abstract][Full Text] [Related]
19. Multidrug therapy for polycystic kidney disease: a review and perspective.
Aguiari G; Catizone L; Del Senno L
Am J Nephrol; 2013; 37(2):175-82. PubMed ID: 23428809
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
Elberg D; Jayaraman S; Turman MA; Elberg G
Exp Cell Res; 2012 Aug; 318(13):1508-16. PubMed ID: 22504005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
